Quantcast

Latest Thousand Oaks, California Stories

2014-06-16 16:25:14

Lung-MAP Trial Will Test Five Investigational Approaches, Including Amgen's Rilotumumab, an Investigational Fully Human Monoclonal Antibody THOUSAND OAKS, Calif., June 16, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a groundbreaking new clinical trial program that will use...

2014-06-10 16:26:06

SANTA MONICA, Calif., June 10, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer, today announced the expansion of Kite's research and development leadership team with the appointments of William Y. Go, M.D., Ph.D., as Senior Director, Clinical Development and Jeff Aycock as Senior Director, Clinical Operations....

2014-06-09 16:25:38

THOUSAND OAKS, Calif., June 9, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the appointment of David W. Meline as executive vice president and chief financial officer (CFO), effective July 21, 2014. He will be responsible for Amgen's finance and investor relations operations, reporting to Robert A. Bradway, chairman and chief executive officer. Meline will succeed Michael A. Kelly, who served as acting CFO since January 2014. Meline, 56, joins Amgen from 3M Company, where...

2014-06-06 16:23:57

THOUSAND OAKS, Calif., June 6, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs Global Healthcare Conference at 1:20 p.m. PT on Wednesday, June 11, 2014, at the Terranea Resort in Rancho Palos Verdes, Calif. Anthony C. Hooper, executive vice president of Global Commercial Operations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of...

2014-06-02 08:30:06

New Chief Medical Officer Brings Wealth of Experience in Innovative Therapies in Oncology SANTA MONICA, Calif., June 2, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer, today announced the appointment of David D. Chang, M.D., Ph.D., as Executive Vice President, Research and Development, and Chief Medical Officer. Dr. Chang brings a substantial...

2014-05-30 16:25:15

THOUSAND OAKS, Calif., May 30, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Jefferies 2014 Global Healthcare Conference at 11:30 a.m. ET on Wednesday, June 4, 2014, at the Grand Hyatt New York in New York City. Arvind Sood, vice president of Investor Relations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available...

2014-05-29 20:22:58

THOUSAND OAKS, Calif., May 29, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will hold a post-American Society of Clinical Oncology (ASCO) summary webcast on Tuesday, June 3, 2014, at 1 p.m. PT. Sean E. Harper, M.D., executive vice president of Research and Development at Amgen, along with members of Amgen's clinical development team, will participate to discuss data presented at ASCO and Amgen's broader oncology portfolio of products. Live audio of the conference...

2014-05-12 16:27:12

Amgen Is Building World's Largest Cancer Support Team THOUSAND OAKS, Calif., May 12, 2014 /PRNewswire/ -- Amgen today announced that four individuals who are an inspiration for others affected by cancer have been selected as Breakaway from Cancer(®) Champions. They will be honored as part of Amgen's Breakaway from Cancer national initiative, designed to raise awareness of the important resources available to those impacted by cancer - from prevention to survivorship - during the ninth annual...

2014-05-12 08:31:40

SANTA MONICA, Calif., May 12, 2014 /PRNewswire/ -- Kite Pharma, Inc. (Kite), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer, today announced the appointment of Jeffrey S. Wiezorek, M.D., M.S., to the newly created position of Vice President, Clinical Development. Dr. Wiezorek will assume responsibilities for leading Kite Pharma's clinical programs upon the retirement of Chief...

2014-05-02 23:07:26

What’s Trending Now™ feature revolutionizes the way that local businesses can market directly to potential patrons in a hyper-local area. Westlake Village, CA (PRWEB) May 02, 2014 Stratosphere Marketing Solutions (http://www.joinstratosphere.com) today announced it has officially launched its new flagship program, ‘All About’, with the new website, AllAboutConejo.com (http://www.allaboutconejo.com); the first in a number of hyper-local B2C websites that will be launched in...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related